fda glp-1 compounding enforcement september 2025 news october 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns FDA – Partnership for Safe Medicines FDA Drug Recalls and Warnings:
Description
Statements Author contributions DK and YT wrote and revised the manuscript
For external use only
The technical framework relies on the NCPDP SCRIPT version 2017071 standard (and its successors)
However, the impact on fibrosis improvement was less consistent, with no significant differences observed between semaglutide and placebo in some trials
